When the process is the product, employee competence is your biggest risk.
Make the Biomanufacturing Education and Training Center at WPI an extension of your training program so your team can hone their skills and learn new capabilities in our pilot plant where the processes are real, but product is not at risk.
Working together, we can deliver customized hands-on programs just for your team. Or you can send staff to our open enrollment programs. The goal is to limit the risk of batch failure with skills development, cross-training, error prevention, and troubleshooting.
This new GroPro supplement is a convenient, ready-to-use human platelet lysate (HPL) formulation that can be used at the same supplementation percentages as fetal bovine serum (FBS) in traditional cultures, but does not require the addition of heparin. HPL has proven to be an excellent, cost effective substitute for FBS in cell culture growth medium without the risk of xenogeneic infections or immune reactions.
First Successful Clone of an Anti-Ebola Therapeutic Antibody Product Candidate
XBiotech, the developer of True Human™ therapeutic antibodies, has successfully isolated and cloned an anti-Ebola product candidate using its True Human antibody discovery platform. The anti-Ebola product candidate was developed from a blood donation received earlier this year from a patient who recovered from Ebola infection.
XBiotech's broad pipeline of True Human antibodies are able to potentially deliver unmatched safety and efficacy because they are cloned directly from individual donors who possess natural immunity against certain targeted diseases. As such, True Human antibodies retain their natural physiology and tolerance profile, having passed the rigors of immune selection in the body.